These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15775264)

  • 21. Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.
    Goto S; Komaba H; Fukagawa M
    NDT Plus; 2008 Aug; 1(Suppl 3):iii2-iii8. PubMed ID: 25983967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term prognosis of parathyroid function in chronic dialysis patients after PEIT-a single-centre trial.
    Tanaka R; Kakuta T; Koiwa F; Fukagawa M; Saito A
    NDT Plus; 2008 Aug; 1(Suppl 3):iii29-iii34. PubMed ID: 25983970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia.
    Basile C; Lomonte C; Vernaglione L; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Cazzato F
    Nephrol Dial Transplant; 2006 Apr; 21(4):968-74. PubMed ID: 16326747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indication and efficacy of PEIT in the management of secondary hyperparathyroidism.
    Koiwa F; Hasegawa T; Tanaka R; Kakuta T
    NDT Plus; 2008 Aug; 1(Suppl 3):iii14-iii17. PubMed ID: 25983965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The progress of ultrasonography imaging about secondary hyperparathyroidism].
    Yamamoto Y; Kitaoka M
    Clin Calcium; 2002 Dec; 12(12):1661-4. PubMed ID: 15775261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ; Slatopolsky E
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local calcitriol injections as a suppressive treatment of secondary hyperparathyroidism in chronic dialysis patients.
    Junik R; Polaáska M; Manitius J; Doroszewski W; Sypniewska G; Gruszka M
    Ren Fail; 2007; 29(8):941-5. PubMed ID: 18067038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperparathyroidism in urology].
    Koide T
    Clin Calcium; 2005 Dec; 15(12):73-8. PubMed ID: 16322677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of percutaneous ethanol injection therapy on subsequent surgical parathyroidectomy.
    Nakamura M; Marui Y; Ubara Y; Nakanishi S; Takemoto F; Takaichi K; Tomikawa S
    NDT Plus; 2008 Aug; 1(Suppl 3):iii39-iii41. PubMed ID: 25983972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
    Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achievement of the Japanese Society for Dialysis Therapy guideline targets for mineral metabolism measures: one Japanese university center result.
    Kimata N; Miwa N; Otsubo S; Iwasaki T; Yabuki Y; Miyabe K; Asamiya Y; Sato K; Sugi O; Ikebe N; Kiuchi K; Mineshima M; Akiba T
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S62-6. PubMed ID: 17976088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management?
    Richards ML; Wormuth J; Bingener J; Sirinek K
    Surgery; 2006 Feb; 139(2):174-80. PubMed ID: 16455325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal failure and vitamin D].
    Brown AJ; Dusso AS; Slatopolsky E
    Clin Calcium; 2002 Jun; 12(6):711-23. PubMed ID: 15775356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients.
    Capuano A; Serio V; Pota A; Memoli B; Andreucci VE
    J Nephrol; 2009; 22(1):59-68. PubMed ID: 19229819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism.
    Abdul Gafor AH; Saidin R; Loo CY; Mohd R; Zainudin S; Shah SA; Norella KC
    Nephrology (Carlton); 2009 Aug; 14(5):488-92. PubMed ID: 19298641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.
    Guideline Working Group, Japanese Society for Dialysis Therapy
    Ther Apher Dial; 2008 Dec; 12(6):514-25. PubMed ID: 19140852
    [No Abstract]   [Full Text] [Related]  

  • 38. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL; Chan TT; Ho YW; Lam SH
    Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence-guided minimally invasive parathyroidectomy: a novel surgical therapy for secondary hyperparathyroidism.
    Prosst RL; Gahlen J; Schnuelle P; Post S; Willeke F
    Am J Kidney Dis; 2006 Aug; 48(2):327-31. PubMed ID: 16860201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease.
    Monier-Faugere MC; Mawad H; Malluche HH
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1255-60. PubMed ID: 17942766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.